Skip to main content
RedHill Biopharma Ltd. (RDHL)
NASDAQ: RDHL · IEX Real-Time Price · USD
0.428
+0.009 (2.22%)
At close: Apr 26, 2024, 4:00 PM
0.429
+0.001 (0.23%)
After-hours: Apr 26, 2024, 7:58 PM EDT

RedHill Biopharma Revenue

In the year 2023, RedHill Biopharma had annual revenue of $6.53M, a decrease of -89.43%.

Revenue (ttm)
$6.53M
Revenue Growth
-90.81%
P/S Ratio
1.95
Revenue / Employee
$123,208
Employees
53
Market Cap
12.71M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20236.53M-55.27M-89.43%
Dec 31, 202261.80M-23.96M-27.94%
Dec 31, 202185.76M21.40M33.25%
Dec 31, 202064.36M58.07M923.03%
Dec 31, 20196.29M-2.07M-24.75%
Dec 31, 20188.36M4.35M108.63%
Dec 31, 20174.01M3.91M3,867.33%
Dec 31, 2016101.00K98.00K3,266.67%
Dec 31, 20153.00K-7.01M-99.96%
Dec 31, 20147.01M7.00M58,350.00%
Dec 30, 201312.00K-4.00K-25.00%
Dec 31, 201216.00K-7.00K-30.43%
Dec 31, 201123.00K--
Dec 31, 20100--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

RDHL News

More News